Paraprotein interferences: Insights from a short study involving multiple platforms and multiple measurands.

Author:

Sarkar Rajarshi1

Affiliation:

1. Drs. Tribedi & Roy Diagnostic Laboratory

Abstract

Abstract Background: Though paraproteinaemic interferences is a well-known phenomenon in clinical chemistry, a large-scale evaluation study involving multiple paraproteinaemic specimens on multiple platforms including multiple measurands with an aim to provide a predictive analysis, is singularly lacking. The present study aims to fill this gap in research. Material & Methods: This cross-sectional non-interventional observational study involved thirteen paraproteinaemic subjects, determined their gamma globulin characterization and measured their total bilirubin, direct bilirubin, HDL-cholesterol, calcium, inorganic phosphate, iron and unsaturated iron binding capacity (UIBC) levels on a dry chemistry platform (Vitros 350) as the established method and two wet chemistry platforms (AU5800 and Cobas 6000) as the evaluation methods. Data thus generated was analyzed for any significant variation and tested if such variation increased with decreasing albumin/ globulin ratio. Results: Significant variation between dry chemistry and wet chemistry measurements were obtained for direct bilirubin, HDL and iron on AU5800 with p-values of 0.0009, <0.0001 and 0.0466 respectively. Similarly, discrepant results were obtained on Cobas 6000 for direct bilirubin and iron, with p-values of <0.0001 and 0.0002 respectively. Additionally, UIBC measurements on AU5800 varied significantly with increasing amounts of paraprotein present in the specimen (p-value = 0.0207). Conclusion: This study emphasizes on predictive analyses to show that paraprotein interferences are fairly common on wet chemistry platforms. Evolving algorithms for monitoring of reaction curves can minimize release of erroneous results due to such interferences.

Publisher

Research Square Platform LLC

Reference33 articles.

1. Drug interference in clinical chemistry: Recommendation of drugs and their concentrations to be used in drug interference studies;Sonntag Oswald;Annals of clinical biochemistry,2001

2. "Interferences in immunoassays: review and practical algorithm";Wauthier Loris;Clinical Chemistry and Laboratory Medicine (CCLM),2022

3. Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic Review;Wadhera RK;Mayo Clin Proc,2010

4. J Backus. Avoiding Incorrect Laboratory Assay Results Caused by Paraproteins. Produced by Ortho Clinical Diagnostics Scientific Affairs Department 2011.

5. Paraproteins are a common cause of interferences with automated chemistry methods;Yang Y;Arch Pathol Lab Med,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3